Related Experiment Video
Updated: Jun 22, 2026

06:19
Optical Trapping of Plasmonic Nanoparticles for In Situ Surface-Enhanced Raman Spectroscopy Characterizations
Published on: June 23, 2022
Plasmonic nanoprobes for SERS biosensing and bioimaging
Tuan Vo-Dinh1, Hsin-Neng Wang, Jonathan Scaffidi
1Fitzpatrick Institute for Photonics, Departments of Biomedical Engineering and Chemistry, Duke University, Durham, NC 27708, USA. tuan.vodinh@duke.edu
Journal of Biophotonics
|June 12, 2009
Summary
This study details plasmonic nanoprobes for disease detection and cellular imaging. These probes utilize surface-enhanced Raman scattering (SERS) for sensitive DNA detection and molecular imaging applications.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Spectroscopy
Background:
- Plasmonic nanoprobes offer unique optical properties for sensitive detection.
- Surface-enhanced Raman scattering (SERS) provides high sensitivity for molecular analysis.
- Current methods face challenges in sensitive and specific disease detection and cellular imaging.
Purpose of the Study:
- To develop and present plasmonic nanoprobes for advanced biosensing and bioimaging.
- To demonstrate the application of SERS gene probes for disease-specific DNA detection.
- To introduce a hyperspectral surface-enhanced Raman imaging (HSERI) system for cellular component identification.
Main Methods:
- Development of plasmonic nanoprobes utilizing silver nanoparticles.
- Application of SERS for DNA hybridization detection of disease-related genes (e.g., HIV, breast cancer).
- Implementation of a HSERI system with Raman dye-labeled nanoparticles for cellular imaging and pH monitoring.
Main Results:
- Successful detection of specific DNA sequences associated with breast cancer using "molecular sentinel" nanoprobes.
- Demonstration of SERS gene probes for detecting target biospecies.
- Successful molecular imaging and pH monitoring in single cells using the HSERI system.
Conclusions:
- Plasmonic nanoprobes are effective tools for sensitive biosensing and high-resolution bioimaging.
- SERS and HSERI technologies enable precise disease detection and cellular analysis.
- The developed nanoprobes and systems hold significant potential for future biomedical applications.

